BioNet-Asia Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Bangkok Thailand (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2016
NCT02946190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

BioNet-Asia | Bionet Co., Ltd

Active Ingredients

Drugs in Phase 2 Trials (3)

boostrix (1 trial)

pertagen (1 trial)

td-pur (1 trial)

Drugs in Phase 1 Trials (1)

covigen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Whooping Cough (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4